VietnamVietnam's pharmaceutical market is growing rapidly but navigating MOH licensing requirements, cold-chain logistics, and a fragmented distributor landscape demands local intelligence. Taevas Global identifies, profiles, and validates compliant distribution
Our distributor identification framework covers every dimension that determines whether a distribution partnership will survive regulatory scrutiny and deliver commercial results in Vietnam.
We systematically catalogue every licensed pharmaceutical distributor operating in Vietnam, segmenting them by therapeutic focus, geographic reach, and GDP-compliant storage capability. This gives you a complete, unbiased view of the addressable partner universe before any outreach begins.
Our four-stage engagement is designed to move quickly without sacrificing the depth that pharmaceutical market entry in Vietnam demands.
We conduct a structured intake session to capture your product portfolio, target therapeutic areas, preferred channel mix, and any existing Vietnam relationships. This brief shapes every subsequent research decision and prevents wasted effort on irrelevant distributor profiles.
The intake session covers product registration status with DAV, pricing strategy, target hospital vs pharmacy channel split, preferred exclusivity model, and any geographic priorities within Vietnam such as Ho Chi Minh City, Hanoi, or secondary cities. We also review any existing MOH correspondence or prior distributor contacts you may have.
Vietnam's pharmaceutical distribution market is dominated by a small number of large national distributors such as Zuellig Pharma and DKSH, but the majority of the market is served by dozens of regional and provincial distributors with limited national reach. Foreign manufacturers must carefully match their distribution partner to their channel strategy, as no single distributor covers all 63 provinces with equal depth.
The Drug Administration of Vietnam requires all pharmaceutical distributors to hold a valid GDP certificate and a distribution business licence under Decree 54/2017/ND-CP and its amendments. Foreign manufacturers are not permitted to distribute directly and must appoint a licensed local entity as the Marketing Authorisation Holder or authorised importer, making distributor selection a regulatory as much as a commercial decision.
Approximately 70 percent of pharmaceutical sales in Vietnam flow through the public hospital tender system, which is governed by Circular 15/2019/TT-BYT and administered at provincial level. Distributors with strong relationships with provincial health departments and a track record of successful tender bids are disproportionately valuable partners for ethical pharmaceutical manufacturers.
Vietnam's growing middle class, increasing non-communicable disease burden, and government investment in universal health coverage are driving demand for innovative branded medicines, biologics, and oncology products. The government's Industry Pharmaceutical Development Strategy to 2030 explicitly targets increasing the proportion of domestically produced and imported innovative drugs, creating a favourable environment for foreign pharmaceutical manufacturers.
The Distributor Identification report for Vietnam Pharmaceuticals is a single, self-contained deliverable that gives your team everything needed to make a confident partner decision.
A structured overview of the pharmaceutical distribution landscape in Vietnam, covering market structure, key player categories, and channel dynamics across hospital, pharmacy, and private clinic segments.
A plain-language summary of DAV and MOH requirements governing pharmaceutical distribution, including GDP certification, import agent registration, and Marketing Authorisation Holder obligations under current Vietnamese law.
A fully researched long list of DAV-licensed distributors meeting your minimum criteria, with standardised profiles covering licence status, therapeutic focus, geographic footprint, and channel specialisation.
Individual compliance scorecards for each shortlisted distributor, assessing GDP certification, enforcement history, MAH capability, and alignment with your product registration pathway.
Visual maps illustrating each shortlisted distributor's provincial coverage, warehouse locations, and hospital tender participation across Vietnam's key regions.
A ranked shortlist of three to five distributors, each with a comprehensive profile covering commercial capability, financial indicators, principal portfolio, key contacts, and Taevas Global's strategic recommendation.
A dedicated risk section identifying compliance gaps, exclusivity conflicts, financial vulnerabilities, and reputational concerns for each shortlisted distributor, with recommended mitigation strategies.
Practical guidance on outreach sequencing, suggested term sheet parameters, key negotiation leverage points, and common contractual pitfalls under Vietnamese distribution law.
You have a product registered or in registration with DAV and need to identify a qualified local distribution partner before your licence is granted. You have limited existing relationships in Vietnam and need an objective, research-driven view of the distributor landscape rather than relying on unsolicited approaches from distributors of unknown quality.
Identify the right pharmaceutical distribution partner in Vietnam with research-backed intelligence, regulatory expertise, and local market knowledge from Taevas Global.